Business Context and Reporting Period
MiMedx Group, Inc. filed this Form 8-K on May 17, 2013, to report the entry into a material definitive agreement. The Company is incorporated in Florida and maintains its principal executive offices in Kennesaw, Georgia.
Key Financial Metrics and Agreement Details
The Company entered into a Loan Agreement with Bank of America, N.A. establishing a secured revolving line of credit.
- Credit Facility: Up to $3,000,000.
- Letters of Credit Sub-limit: Up to $1,000,000.
- Collateral: Secured by the Company's accounts receivable and inventory.
- Interest Rate: LIBOR plus 2%.
- Maturity Date: May 1, 2014.
- Utilization: As of the filing date, no drawings have been made under the facility.
The filing text does not provide current revenue, profit, cash flow, or existing debt levels outside of this new facility.
Material Changes and Covenants
This filing represents a new material financial obligation. The Loan Agreement imposes significant restrictions and covenants on the Company, including:
- Operational Restrictions: Limits on mergers, acquisitions, incurring new liens, additional indebtedness, asset sales outside the ordinary course, and engaging in substantially different business activities without lender consent.
- Financial Covenants: Requirements to maintain a minimum funded debt to adjusted EBITDA ratio and a minimum fixed charge coverage ratio.
- Prepayment Penalties: Applicable upon earlier termination of the Revolving Line of Credit.
Risks, Contingencies, and Events of Default
The agreement defines several events of default, subject to cure periods, including:
- Non-payment of principal, interest, or fees.
- Defaults under other agreements with the Lender or other credit agreements.
- Bankruptcy, insolvency, or liquidation events.
- Materially false or misleading information provided to the Lender.
- Judgments or arbitration awards against the Company in excess of $250,000.
- Material adverse changes in the Company's condition.
- Government actions materially adversely affecting the Company.
- Events related to ERISA Title IV Plans.
Investor Verification Checklist
- Verify the specific thresholds for the "minimum funded debt to adjusted EBITDA ratio" and "minimum fixed charge coverage ratio" in the full Loan Agreement (Exhibit 10.1).
- Confirm the Company's current accounts receivable and inventory levels to assess the adequacy of collateral coverage.
- Review the Company's existing debt load to understand the impact of the new covenants on future borrowing capacity.
- Monitor future filings for any drawings on the line of credit or covenant compliance reports.